Explainer

Omega-3 for ADHD: What Fish Oil Trials and Reviews Actually Show

A 2023 Cochrane review of 37 trials found omega-3 supplements had no effect on parent-rated ADHD symptoms in kids. What EPA, DHA, dose and safety data show.

Mental Health Stats Research Team 7 min read

Key Takeaways

  • The 2023 Cochrane review of 37 trials found high-certainty evidence that omega-3 and other PUFA supplements had no effect on parent-rated total ADHD symptoms in children and teens (SMD −0.08; 16 studies, 1,166 participants)[1].−0.08[1]
  • Earlier meta-analyses reported small benefits, including a standardized mean difference of 0.31 across 10 trials with 699 children in 2011[2].0.31[2]
  • The omega-3 effect in a 2014 analysis was about one-quarter the size of the typical effect of ADHD medication[3].1/4[3]
  • Youth with ADHD have lower average blood DHA, EPA and total omega-3 levels than peers, based on 6 to 7 case-control studies per measure in a 2018 meta-analysis[4].Lower DHA[4]
  • Overall side effects did not differ between omega-3 and placebo groups in 8 trials with 591 participants (risk ratio 1.02)[1].1.02[1]
  • In a Danish trial of 700 mother-child pairs, 2.4 g a day of fish oil in late pregnancy did not significantly reduce ADHD at age 10[5].700 pairs[5]

Does Omega-3 Help ADHD? What the Largest Review Found

The current evidence on omega-3 for ADHD points to little or no effect on core symptoms in children and teens. The 2023 Cochrane review of polyunsaturated fatty acids (PUFA), which pooled 37 trials with more than 2,374 participants, found high-certainty evidence that supplements did not change parent-rated total symptoms of ADHD[1].

The pooled standardized mean difference for parent-rated total symptoms was −0.08 (16 studies, 1,166 participants), and scores for inattention (−0.01) and hyperactivity-impulsivity (0.09) also did not differ from placebo[1].

One finding pointed the other way. Low-certainty evidence from 3 studies with 191 participants suggested that children taking PUFA were more likely to be rated as improved (risk ratio 1.95)[1].

NIH's National Center for Complementary and Integrative Health (NCCIH) describes the research as conflicting and says it is uncertain whether omega-3s have any benefit for ADHD symptoms[6]. How often ADHD is diagnosed, and in whom, is tracked on the ADHD statistics page.

Effect of omega-3 and other PUFA supplements on parent-rated total ADHD symptoms versus placebo (16 trials, 1,166 children and teens)
SMD −0.08

A standardized mean difference this close to zero means supplement and placebo groups ended with nearly identical symptom scores. Cochrane rated the finding high certainty.

"PUFA had no effect on parent-rated total ADHD symptoms"

Gillies D, et al. (Cochrane Database of Systematic Reviews)(2023) View Source
How to read these numbers: Most omega-3 trials report a standardized mean difference (SMD) or Hedges' g, which expresses the gap between the supplement and placebo groups in standard-deviation units. A value near zero means no difference. Reviews use different sign conventions, so this article states the direction of each result in words.

EPA, DHA and ALA

Omega-3s are polyunsaturated fats. EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are the long-chain forms found in fish, fish oil and krill oil, while ALA (alpha-linolenic acid) comes from plant oils such as flaxseed, soybean and canola. The body converts ALA to EPA and DHA at reported rates below 15%, so eating or supplementing EPA and DHA directly is the only practical way to raise their levels[7].

Related Terms

fish oil
PUFA
omega-6
krill oil
algal oil

Source: NIH Office of Dietary Supplements

Major Reviews of Omega-3 Supplements for ADHD

ReviewYearTrialsParticipantsFinding on ADHD symptoms
Bloch & Qawasmi (JAACAP)201110699Small benefit (SMD 0.31); larger with more EPA
Hawkey & Nigg (Clin Psychol Rev)2014161,408Small benefit (g = 0.26)
Chang et al. (Neuropsychopharmacology)20187534Small-to-moderate benefit (g = 0.38)
Cochrane (Gillies et al.)202337 (16 pooled)2,374+ (1,166 pooled)No effect on parent-rated total symptoms
Liu et al. (J Clin Psychiatry)2023221,789No significant effect overall; benefit in trials of 4+ months

Meta-analyses of randomized, placebo-controlled trials of omega-3 or PUFA supplements in children and adolescents with ADHD or ADHD symptoms[2][3][4][1][8].

1Cochrane's pooled total-symptom result covers 16 of its 37 trials; other outcomes drew on different subsets[1].

2Hawkey and Nigg also pooled 9 studies (586 participants) of blood omega-3 levels[3].

Sources

  • •Bloch & Qawasmi, 2011
  • •Hawkey & Nigg, 2014
  • •Chang et al., 2018
  • •Cochrane, 2023
  • •Liu et al., 2023

Why Do Reviews of Fish Oil for ADHD Disagree?

Earlier meta-analyses reported small benefits. A 2011 Yale review of 10 trials with 699 children found a standardized mean difference of 0.31, and a 2018 review of 7 trials with 534 youth reported a Hedges' g of 0.38 on clinical symptom scores[2][4].

Newer pooled analyses that included more trials found less. A 2023 meta-analysis of 22 studies with 1,789 participants found no significant improvement in core ADHD symptoms (SMD −0.16, P = .07)[8]. Its authors attributed the inconsistent results across studies to differences in dose, omega-3 composition and treatment duration[8].

Who rates the child also matters. In the 2014 Hawkey and Nigg analysis, the effect was g = 0.22 by parent report and 0.17 by teacher report, and inattention improved reliably only in parent ratings[3].

Duration may matter too. Among trials lasting at least 4 months, omega-3s outperformed placebo (SMD −0.35), though this was a subgroup result built on small samples[8].

Single trials cut both ways. In a French trial of 162 children aged 6 to 15, ADHD Rating Scale scores fell 19% on placebo and 9.7% on DHA-EPA over 3 months, a difference that favored placebo[9].

Do People With ADHD Have Low Omega-3 Levels?

On average, yes. A 2018 meta-analysis found lower blood DHA (7 studies, 412 participants), EPA (7 studies, 468 participants) and total omega-3 (6 studies, 396 participants) in children and adolescents with ADHD than in controls[4].

A 2014 analysis of 9 studies with 586 participants reached the same conclusion, with a pooled effect of g = 0.42 for lower omega-3 blood levels in ADHD[3].

Lower levels do not show that a shortage causes ADHD. A 2024 Mendelian randomization study, which uses genetic variants as stand-ins for lifelong fatty acid levels, did not support a causal link between unsaturated fatty acid levels and childhood or adult ADHD[10].

NCCIH notes some evidence that ADHD could be related to lower dietary omega-3 and higher omega-6 intake, which remains an association rather than a demonstrated cause[6]. The established risk factors are covered in what causes ADHD.

EPA vs. DHA: Which Omega-3 and What Dose Did Trials Use?

Older analyses favored EPA. The 2011 Yale meta-analysis found that the EPA dose in a supplement was significantly correlated with its efficacy[2]. The 2014 analysis likewise linked larger EPA doses to greater symptom reduction and found no added benefit from larger DHA doses[3].

The 2023 meta-analysis did not confirm this: neither a high EPA dose nor a high EPA-to-DHA ratio improved ADHD symptoms[8].

A 2019 trial randomized 103 youth aged 6 to 18 to 1.2 g of EPA a day or soybean oil for 12 weeks, and 92 completed it[11]. EPA modestly improved focused attention overall (effect size 0.38) and did more for those with the lowest starting EPA levels (0.89 for reaction time, 0.83 for vigilance)[11].

The same trial found a possible downside. Youth taking EPA improved less than those on placebo in impulsivity, most clearly among those who started with the highest EPA levels[11].

No official omega-3 dose exists for ADHD. U.S. intake targets cover only ALA, not EPA or DHA: the Adequate Intake is 0.9 g a day at ages 4 to 8 and 1.6 g for men and 1.1 g for women[7].

How Does Omega-3 Compare With ADHD Medication?

Omega-3 effects are much smaller than those of standard ADHD medications. Citing a review of drug trials, Hawkey and Nigg put the typical medication effect size at about 1.0 and judged the omega-3 effect to be one-quarter as large[3].

Bloch and Qawasmi described omega-3's efficacy as modest compared with psychostimulants, atomoxetine and alpha-2 agonists[2]. Citing the benign side-effect profile, they judged it a reasonable add-on to medication or an option for families reluctant to use psychiatric drugs, a 2011 conclusion that predates the 2023 Cochrane finding of no effect on parent-rated symptoms[2][1].

The 2021 World Federation of ADHD consensus statement described omega-3 effects as small-to-medium in three meta-analyses and tiny in a fourth that covered 18 studies and 1,640 participants[12].

How omega-3 fits beside the treatments with stronger evidence is laid out in treating ADHD by age and behavior therapy for ADHD.

Is Fish Oil Safe for Children With ADHD?

In ADHD trials, side effects were about as common on omega-3 as on placebo. Cochrane found moderate-certainty evidence of no difference in overall side effects (risk ratio 1.02; 8 studies, 591 participants)[1].

The side effects most often reported for omega-3 supplements are mild: unpleasant taste, bad breath, heartburn, nausea, diarrhea, headache and odorous sweat[7].

In the French trial, 2 children taking DHA-EPA and none taking placebo were hospitalized for worsening ADHD symptoms[9].

No upper intake limit has been set for omega-3s, and FDA has concluded that supplements providing no more than 5 g a day of EPA and DHA are safe when used as recommended[7]. Doses of 2 to 15 g a day might lengthen bleeding time, and labels for prescription omega-3 products call for periodic INR checks in people taking anticoagulants[7].

Fish liver oils such as cod liver oil also contain vitamins A and D, which can be harmful in excessive amounts[6].

Omega-3 in Pregnancy, Adulthood and the Diet

Pregnancy

Fish oil in pregnancy has not been shown to prevent ADHD. In a Danish randomized trial of 700 mother-child pairs, 2.4 g of fish oil a day from late pregnancy did not significantly reduce ADHD at age 10 (odds ratio 0.79)[5].

Higher maternal DHA and EPA blood levels were linked to lower ADHD risk in that cohort before adjustment, but the link was no longer significant after accounting for confounders[5]. A 2020 review for the Dietary Guidelines Advisory Committee likewise found insufficient evidence to judge whether omega-3 supplements taken in pregnancy or while breastfeeding affect ADHD risk[6].

Adults

The main trial evidence comes from young people. The Cochrane review, the 2018 meta-analysis and the 2011 Yale review all covered children or adolescents, so their results do not transfer directly to adults with ADHD[1][4][2]. Adult options are reviewed in ADHD treatment for adults.

Food versus supplements

A 3-ounce serving of cooked farmed Atlantic salmon provides about 1.24 g of DHA and 0.59 g of EPA[7]. Federal dietary guidelines recommend that adults eat 8 ounces or more of seafood a week, with smaller amounts for young children[6].

Algal oils are a vegetarian source of DHA, and some also contain EPA[6]. For some health conditions, NCCIH notes, the evidence of benefit is stronger for eating seafood than for taking omega-3 supplements[6].

Frequently Asked Questions

Sources & References

  1. Gillies D, Leach MJ, Perez Algorta G. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews. Published 2023. Accessed October 2026. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007986.pub3/full [Link]
  2. Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry. Published 2011. Accessed October 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC3625948/ [Link]
  3. Hawkey E, Nigg JT. Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clinical Psychology Review. Published 2014. Accessed October 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC4321799/ [Link]
  4. Chang JP, Su KP, Mondelli V, Pariante CM. Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology. Published 2018. Accessed October 2026. https://www.nature.com/articles/npp2017160 [Link]
  5. Rosenberg JB, Sevelsted A, Jepsen JRM, et al. Fish oil-derived fatty acids during pregnancy and risk of neurodevelopmental disorders in children at age 10: a randomized controlled trial. Translational Psychiatry. Published 2026. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/42393063/ [Link]
  6. National Center for Complementary and Integrative Health. Omega-3 Supplements: What You Need To Know. NCCIH. Published 2024. Accessed October 2026. https://www.nccih.nih.gov/health/omega3-supplements-what-you-need-to-know [Link]
  7. Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. National Institutes of Health. Published 2025. Accessed October 2026. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/ [Link]
  8. Liu TH, Wu JY, Huang PY, et al. Omega-3 polyunsaturated fatty acids for core symptoms of attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry. Published 2023. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/37656283/ [Link]
  9. Cornu C, Mercier C, Ginhoux T, et al. A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms. European Child & Adolescent Psychiatry. Published 2018. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/28993963/ [Link]
  10. Wang Z, Zhu H, Chen L, et al. Absence of causal relationship between levels of unsaturated fatty acids and ADHD: evidence from Mendelian randomization study. Journal of Attention Disorders. Published 2024. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/39082434/ [Link]
  11. Chang JP, Su KP, Mondelli V, et al. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels. Translational Psychiatry. Published 2019. Accessed October 2026. https://www.nature.com/articles/s41398-019-0633-0 [Link]
  12. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. Published 2021. Accessed October 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC8328933/ [Link]

Related Statistics